Loading...
Anatara Lifesciences Ltd
ANR.AX•ASX
Healthcare
Biotechnology
$0.00(0.00%)
Australian Market opens in 4h 21mAnatara Lifesciences Ltd (ANR.AX) AI-Powered Stock Analysis
See how Anatara Lifesciences Ltd scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerAnatara Lifesciences Ltd (ANR.AX) Stock Overall Grade
Anatara Lifesciences Ltd’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Anatara Lifesciences Ltd's overall stock rating.
Forecast
CScore
49/100Financial Growth
AScore
80/100Fundamental Growth
BScore
61/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
C+Score
50/100Anatara Lifesciences Ltd (ANR.AX) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 49/100 (C), reflecting weak confidence in its potential. Financial Growth (80/100, A) and Fundamental Growth (61/100, B) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Anatara Lifesciences Ltd stock grade, including financials, comparisons, and forecasts.